Glenmark gets FDA nod for rosuvastatin calcium tablets

Quoting IMS sales data for the 12 months to May 2016, Glenmark said Rosuvastatin calcium tablets achieved annual sales of around USD 6.78 billion.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news